NCT02977143

Brief Summary

In urologic robotic surgery with steep Trendelenburg position, maintenance of cardiac preload and cardiac output is important for clinical prognosis. Previous studies reported the positive end-expiratory pressure (PEEP)-induced increase in central venous pressure (CVP) could be a accurate predictor of fluid responsiveness in cardiac surgical patients. The authors attempt to evaluate the predictability of PEEP-induced increase in CVP as well as stroke volume variation in urologic robotic surgery with Steep Trendelenburg position.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

November 27, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 30, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

April 3, 2018

Status Verified

April 1, 2018

Enrollment Period

4 months

First QC Date

November 27, 2016

Last Update Submit

April 1, 2018

Conditions

Keywords

fluid responsivenesscentral venous pressurepositive end-expiratory pressurerobot surgery

Outcome Measures

Primary Outcomes (1)

  • fluid responsiveness

    fluid responsiveness is determined when increase in cardiac index is more than 10%

    5 minutes after administration of 300 ml volulyte

Secondary Outcomes (22)

  • central venous pressure

    one hour after the initiation of pneumoperitoneum

  • cardiac index

    one hour after the initiation of pneumoperitoneum

  • stroke volume variation

    one hour after the initiation of pneumoperitoneum

  • abdominal pressure

    one hour after the initiation of pneumoperitoneum

  • central venous pressure

    5 minutes after the application of positive end-expiratory pressure of 10 cmH2O

  • +17 more secondary outcomes

Study Arms (1)

Fluid responsiveness test

EXPERIMENTAL

First, apply 10 cmH2O positive endexpiratory pressure (PEEP) and measure the increase in central venous pressure (CVP) as well as other preload indexes (central venous pressure, mean arterial pressure, stroke volume variation). Second, measure the increase in cardiac index after administration of volulyte 300 ml. If cardiac index increase more than 10%, fluid responsiveness is confirmed.

Procedure: Fluid loading of volulyte 300 ml

Interventions

Administration of volulyte 300 ml and measurement of increase in cardiac index

Fluid responsiveness test

Eligibility Criteria

Age20 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient undergoing robot-assisted laparoscopic radical prostatectomy or cystectomy.
  • American Society of Anesthesiologist Physical Status Classification of 1, 2 or 3.

You may not qualify if:

  • Medical history of arrhythmia or new-onset arrhythmia after anesthesia induction.
  • Valvular or ischemic heart disease or left ventricular ejection fraction less than 40%.
  • Any significant pulmonary disease or history of chronic obstructive pulmonary disease
  • End-stage renal disease or preoperative creatinine \> 1.4 mg/dl

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Prostatic NeoplasmsUrinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesUrologic NeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrinary Bladder DiseasesUrologic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

November 27, 2016

First Posted

November 30, 2016

Study Start

November 1, 2016

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

April 3, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations